In two different sessions, Subject Matter Experts from Navitas will address new challenges facing the life science industry created by the acceleration of the globalization of the life science industry.

March 14, 2016, Princeton, New Jersey: Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting In June

Two experts from Navitas will be speaking in Philadelphia at DIA’s 52nd annual meeting in June.

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing the life science industry created by the acceleration of the globalization of the life science industry, new regulatory requirements and unprecedented merger and acquisition activity. They will talk about solutions to these challenges, demonstrating real world approaches derived from successful pharma company projects, and insights from Navitas’ industry leading networks pvnet® and labelnet®. Our networks are independent communities where life science leaders facing similar challenges exchange insights, compare performance, and debate strategies to tackle the latest hot issues. With over 100 members from the world’s leading life science companies, each network has a focused and evolving agenda to meet the latest challenges.

Tuesday, June 28th 10:30am: Hershell Thompson will chair “The Global Conundrum: Herding Cats – Identifying Risk Across Pharmacovigilance Networks and Seeking Simplicity in Multi – Country Pharmacovigilance Activities”. Along with Lesia Tontisakis of Allergan and others, this session explores the Pharmacovigilance (PV) Affiliate Network from both corporate and local perspectives, reviews case studies of issues faced by companies of all sizes, from start-up to multi-national. In addition, an approach to clarifying the current affiliate situation using an affiliate’s survey tool, as well as available in-house data sources will be presented. Also, how risk-assessment approaches can be applied to generate a clear view of systemic risk (exposure across all or many affiliates) and unique risks (exposure specific to one particular or a few local affiliates). Finally, methods to streamline PV affiliate processes and the benefits this approach provides to the enterprise with be highlighted.

Tuesday, June 28th 4:30pm: Denis Fung and Brenda Crowe of Eli Lilly will present “Improving Adverse Drug Reaction Information in Product Labels”. Adverse drug reactions (ADRs) are an important part of a product label. This session will recommend ways to make ADR information in product labels more understandable and better reflective of the risk of a drug relative to a comparator. The session will also explore the importance of end-to-end labeling and tracking to ensure pharmacovigilance compliance.

About Navitas:
The Navitas team has been assembled bringing together the proven expert teams of TAKE Life Sciences and WCI Consulting and, adding to this core, a range of experts from the worlds of Clinical Development, Regulatory, Technology, and Consulting. We have built the Navitas team specifically to deliver insight to our clients, to develop pragmatic solutions together, and to support their deployment and operation. We deliver advice, solutions, and services in Clinical, Regulatory, Safety, and Content Management. We are proud that our legacy businesses have served the sector for some 15 years and have allowed us to work with 100 of the top Life Science companies. Our team has now grown to over 400 staff.

We pride ourselves in our role as Expert Navigators. Interpreting market and regulatory change; driving collaboration across companies; seeking the simple solution to the complex problem; investing to enable the changes. We are motivated by the success of our clients and thrive on working together with clients, partners, and each other, across geographies, time zones, and cultures. For more information, visit www.navitas.net.

 

Latest News

20
Apr2017

ICH Reflection on “GCP Renovation”: Modernization of ICH E8 and...

Navitas welcomes the opportunity to provide comments on this Reflection Paper... Navitas welcomes the opportunity...

13
Apr2017

Navitas Life Sciences Augments Global Executive Management Team

Navitas Life Sciences announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer....

24
Jan2017

Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums... ...

17
Jan2017

Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring...

02
Nov2016

BioVectra chooses pharmaREADY for eCTD Solution

BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures...

05
Oct2016

Navitas at DIA's 10th Annual Forum for Qualified Persons...

Navitas Principal Jeffrey Ho will present "Efficient content management for the compilation and...

04
Oct2016

News 2016

[row id="1" class="ROW_CLASS"] [col class="span12"] 02 Nov 2016 AbbVie and Navitas Present Case Study on the Evolution...

27
Sep2016

Navitas releases paper on CDISC, the standards and why the...

The FDA (and eventually, regulatory agencies from around the world) will require clinical data...

13
Sep2016

AbbVie and Navitas Present Case Study on the Evolution and...

At 10:30a.m. (East Coast Time) on September 22nd, Navitas and AbbVie will...

29
Jul2016

Navitas Networks announce Forum dates for Autumn, 2016

The Navitas Networks are pleased to confirm the dates for our upcoming Autumn forums....

12
Jul2016

Navitas Celebrates 100th pharmaREADY customer

pharmaREADY is Navitas’ intuitive and easy to use, fully integrated, regulatory compliant, web-based suite...

28
Jun2016

Navitas' PVTech Summit Defines Future Success

Navitas’ PVTech Summit was held on June 15th at the Hudson Hotel in New...

18
May2016

Navitas Welcomes Tara Baer to Navitas

Navitas is pleased to welcome Tara Baer, who joins Navitas' Regulatory Practice. With over...

18
May2016

Navitas Speaks at Sparta Connection in Orlando

David Gwyn, Navitas' Technology Practice lead, will unveil idmpREADY at the Sparta Connection conference...

14
Mar2016

Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing...

09
Mar2016

Navitas is pleased to announce the introduction of our networks...

Navitas' inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. ...

25
Jan2016

Navitas Announces the Inaugural pvindia Forum

Navitas will soon be adding to our portfolio of industry leading networks with the...

18
Jan2016

Navitas Relaunches pharmaREADY.com

pharmaREADY.com is Navitas' next generation website for its fully integrated, regulatory compliant document management,...

14
Dec2015

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and...

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and Future of the Pharmaceutical...

03
Nov2015

The changing trends in drivers of life sciences R D...

Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales...